DIEBOLD NIXDORF INC (DBD) Stock Fundamental Analysis
USA - NYSE:DBD - US2536512021 - Common Stock
59.1 USD
-0.71 (-1.19%)
59.1 USD
0 (0%)
DBD gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 33 industry peers in the Technology Hardware, Storage & Peripherals industry. Both the profitability and the financial health of DBD get a neutral evaluation. Nothing too spectacular is happening here. DBD has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year DBD was profitable.
DBD had a positive operating cash flow in the past year.
In the past 5 years DBD reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: DBD reported negative operating cash flow in multiple years.
1.2 Ratios
With a Return On Assets value of -0.34%, DBD perfoms like the industry average, outperforming 57.58% of the companies in the same industry.
DBD's Return On Equity of -1.18% is fine compared to the rest of the industry. DBD outperforms 69.70% of its industry peers.
The Return On Invested Capital of DBD (8.61%) is better than 66.67% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for DBD is significantly below the industry average of 14.98%.
The 3 year average ROIC (5.12%) for DBD is below the current ROIC(8.61%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.34% | ||
| ROE | -1.18% | ||
| ROIC | 8.61% |
ROA(3y)4.54%
ROA(5y)0.8%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.12%
ROIC(5y)5.58%
1.3 Margins
DBD's Operating Margin of 7.32% is fine compared to the rest of the industry. DBD outperforms 72.73% of its industry peers.
In the last couple of years the Operating Margin of DBD has grown nicely.
DBD's Gross Margin of 25.44% is on the low side compared to the rest of the industry. DBD is outperformed by 60.61% of its industry peers.
In the last couple of years the Gross Margin of DBD has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.32% | ||
| PM (TTM) | N/A | ||
| GM | 25.44% |
OM growth 3Y20.78%
OM growth 5Y40.66%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.32%
GM growth 5Y0.68%
2. Health
2.1 Basic Checks
DBD has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
DBD has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, DBD has less shares outstanding
The debt/assets ratio for DBD has been reduced compared to a year ago.
2.2 Solvency
DBD has an Altman-Z score of 1.87. This is not the best score and indicates that DBD is in the grey zone with still only limited risk for bankruptcy at the moment.
DBD's Altman-Z score of 1.87 is in line compared to the rest of the industry. DBD outperforms 48.48% of its industry peers.
The Debt to FCF ratio of DBD is 4.62, which is a neutral value as it means it would take DBD, 4.62 years of fcf income to pay off all of its debts.
DBD has a better Debt to FCF ratio (4.62) than 66.67% of its industry peers.
A Debt/Equity ratio of 0.85 indicates that DBD is somewhat dependend on debt financing.
DBD's Debt to Equity ratio of 0.85 is on the low side compared to the rest of the industry. DBD is outperformed by 63.64% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.85 | ||
| Debt/FCF | 4.62 | ||
| Altman-Z | 1.87 |
ROIC/WACC0.92
WACC9.36%
2.3 Liquidity
DBD has a Current Ratio of 1.36. This is a normal value and indicates that DBD is financially healthy and should not expect problems in meeting its short term obligations.
DBD has a Current ratio (1.36) which is in line with its industry peers.
DBD has a Quick Ratio of 1.36. This is a bad value and indicates that DBD is not financially healthy enough and could expect problems in meeting its short term obligations.
DBD has a Quick ratio of 0.91. This is comparable to the rest of the industry: DBD outperforms 54.55% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.36 | ||
| Quick Ratio | 0.91 |
3. Growth
3.1 Past
DBD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.20%, which is quite good.
The Earnings Per Share has been growing by 69.69% on average over the past years. This is a very strong growth
Looking at the last year, DBD shows a decrease in Revenue. The Revenue has decreased by -3.75% in the last year.
The Revenue has been decreasing by -3.18% on average over the past years.
EPS 1Y (TTM)13.2%
EPS 3Y69.69%
EPS 5YN/A
EPS Q2Q%-18.26%
Revenue 1Y (TTM)-3.75%
Revenue growth 3Y-1.33%
Revenue growth 5Y-3.18%
Sales Q2Q%-2.61%
3.2 Future
The Earnings Per Share is expected to grow by 11.87% on average over the next years. This is quite good.
DBD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.83% yearly.
EPS Next Y-9.47%
EPS Next 2Y12.54%
EPS Next 3Y11.87%
EPS Next 5YN/A
Revenue Next Year2.09%
Revenue Next 2Y2.41%
Revenue Next 3Y2.83%
Revenue Next 5YN/A
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 20.88, DBD is valued on the expensive side.
Compared to the rest of the industry, the Price/Earnings ratio of DBD indicates a somewhat cheap valuation: DBD is cheaper than 72.73% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.20. DBD is valued slightly cheaper when compared to this.
DBD is valuated correctly with a Price/Forward Earnings ratio of 12.09.
Based on the Price/Forward Earnings ratio, DBD is valued a bit cheaper than the industry average as 72.73% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.70. DBD is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.88 | ||
| Fwd PE | 12.09 |
4.2 Price Multiples
96.97% of the companies in the same industry are more expensive than DBD, based on the Enterprise Value to EBITDA ratio.
81.82% of the companies in the same industry are more expensive than DBD, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.74 | ||
| EV/EBITDA | 6.99 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.54%
EPS Next 3Y11.87%
5. Dividend
5.1 Amount
No dividends for DBD!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
59.1
-0.71 (-1.19%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)
Earnings (Next)
Inst Owners106.19%
Inst Owner Change-3.27%
Ins Owners1.75%
Ins Owner Change0.24%
Market Cap2.16B
Analysts82.86
Price Target77.18 (30.59%)
Short Float %2.04%
Short Ratio3.59
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)30.65%
Min EPS beat(2)1.76%
Max EPS beat(2)59.55%
EPS beat(4)2
Avg EPS beat(4)0.05%
Min EPS beat(4)-52.17%
Max EPS beat(4)59.55%
EPS beat(8)5
Avg EPS beat(8)9.34%
EPS beat(12)7
Avg EPS beat(12)-88.46%
EPS beat(16)8
Avg EPS beat(16)-91.11%
Revenue beat(2)1
Avg Revenue beat(2)0.84%
Min Revenue beat(2)-1.34%
Max Revenue beat(2)3.02%
Revenue beat(4)1
Avg Revenue beat(4)-0.11%
Min Revenue beat(4)-1.34%
Max Revenue beat(4)3.02%
Revenue beat(8)4
Avg Revenue beat(8)0.04%
Revenue beat(12)4
Avg Revenue beat(12)-0.96%
Revenue beat(16)4
Avg Revenue beat(16)-2.35%
PT rev (1m)4.61%
PT rev (3m)4.61%
EPS NQ rev (1m)-2.88%
EPS NQ rev (3m)-10.62%
EPS NY rev (1m)-1.42%
EPS NY rev (3m)-1.42%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.82%
Revenue NY rev (1m)1.05%
Revenue NY rev (3m)1.05%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.88 | ||
| Fwd PE | 12.09 | ||
| P/S | 0.59 | ||
| P/FCF | 10.74 | ||
| P/OCF | 9.56 | ||
| P/B | 1.97 | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.99 |
EPS(TTM)2.83
EY4.79%
EPS(NY)4.89
Fwd EY8.27%
FCF(TTM)5.5
FCFY9.31%
OCF(TTM)6.18
OCFY10.46%
SpS100.25
BVpS29.95
TBVpS-9.82
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.34% | ||
| ROE | -1.18% | ||
| ROCE | 10.9% | ||
| ROIC | 8.61% | ||
| ROICexc | 9.77% | ||
| ROICexgc | 29.69% | ||
| OM | 7.32% | ||
| PM (TTM) | N/A | ||
| GM | 25.44% | ||
| FCFM | 5.49% |
ROA(3y)4.54%
ROA(5y)0.8%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.12%
ROIC(5y)5.58%
ROICexc(3y)6.13%
ROICexc(5y)6.88%
ROICexgc(3y)21.8%
ROICexgc(5y)29.05%
ROCE(3y)6.48%
ROCE(5y)7.06%
ROICexcg growth 3Y-11.73%
ROICexcg growth 5Y37.89%
ROICexc growth 3Y4.77%
ROICexc growth 5Y35.34%
OM growth 3Y20.78%
OM growth 5Y40.66%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.32%
GM growth 5Y0.68%
F-Score4
Asset Turnover0.98
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.85 | ||
| Debt/FCF | 4.62 | ||
| Debt/EBITDA | 2.31 | ||
| Cap/Depr | 18.6% | ||
| Cap/Sales | 0.68% | ||
| Interest Coverage | 2.84 | ||
| Cash Conversion | 56.26% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.36 | ||
| Quick Ratio | 0.91 | ||
| Altman-Z | 1.87 |
F-Score4
WACC9.36%
ROIC/WACC0.92
Cap/Depr(3y)16.93%
Cap/Depr(5y)15.92%
Cap/Sales(3y)0.61%
Cap/Sales(5y)0.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.2%
EPS 3Y69.69%
EPS 5YN/A
EPS Q2Q%-18.26%
EPS Next Y-9.47%
EPS Next 2Y12.54%
EPS Next 3Y11.87%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.75%
Revenue growth 3Y-1.33%
Revenue growth 5Y-3.18%
Sales Q2Q%-2.61%
Revenue Next Year2.09%
Revenue Next 2Y2.41%
Revenue Next 3Y2.83%
Revenue Next 5YN/A
EBIT growth 1Y3.35%
EBIT growth 3Y19.17%
EBIT growth 5Y36.19%
EBIT Next Year24.02%
EBIT Next 3Y13.05%
EBIT Next 5YN/A
FCF growth 1Y145.49%
FCF growth 3Y8.67%
FCF growth 5Y113.09%
OCF growth 1Y154.49%
OCF growth 3Y6.68%
OCF growth 5Y26.59%